JP6854246B2 - 尿サンプルの分析方法 - Google Patents

尿サンプルの分析方法 Download PDF

Info

Publication number
JP6854246B2
JP6854246B2 JP2017564356A JP2017564356A JP6854246B2 JP 6854246 B2 JP6854246 B2 JP 6854246B2 JP 2017564356 A JP2017564356 A JP 2017564356A JP 2017564356 A JP2017564356 A JP 2017564356A JP 6854246 B2 JP6854246 B2 JP 6854246B2
Authority
JP
Japan
Prior art keywords
lysis buffer
buffer
mcm5
sample
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017564356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018523110A (ja
JP2018523110A5 (cg-RX-API-DMAC7.html
Inventor
ニコラス ミラー−ジョーンズ，デビッド
ニコラス ミラー−ジョーンズ，デビッド
ストックリー，ジャクリーン
ナイバーグ，シェリル
Original Assignee
アーケア ダイアグノスティクス リミテッド
アーケア ダイアグノスティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1509909.6A external-priority patent/GB201509909D0/en
Priority claimed from GBGB1603559.4A external-priority patent/GB201603559D0/en
Application filed by アーケア ダイアグノスティクス リミテッド, アーケア ダイアグノスティクス リミテッド filed Critical アーケア ダイアグノスティクス リミテッド
Publication of JP2018523110A publication Critical patent/JP2018523110A/ja
Publication of JP2018523110A5 publication Critical patent/JP2018523110A5/ja
Application granted granted Critical
Publication of JP6854246B2 publication Critical patent/JP6854246B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/34—Purifying; Cleaning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/575—
    • G01N33/57555—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
    • G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2017564356A 2015-06-08 2016-06-01 尿サンプルの分析方法 Expired - Fee Related JP6854246B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1509909.6 2015-06-08
GBGB1509909.6A GB201509909D0 (en) 2015-06-08 2015-06-08 Methods
GB1603559.4 2016-03-01
GBGB1603559.4A GB201603559D0 (en) 2016-03-01 2016-03-01 Methods
PCT/GB2016/051608 WO2016198833A2 (en) 2015-06-08 2016-06-01 Methods

Publications (3)

Publication Number Publication Date
JP2018523110A JP2018523110A (ja) 2018-08-16
JP2018523110A5 JP2018523110A5 (cg-RX-API-DMAC7.html) 2019-07-04
JP6854246B2 true JP6854246B2 (ja) 2021-04-07

Family

ID=56113001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017564356A Expired - Fee Related JP6854246B2 (ja) 2015-06-08 2016-06-01 尿サンプルの分析方法

Country Status (6)

Country Link
US (2) US11519916B2 (cg-RX-API-DMAC7.html)
EP (1) EP3304082B1 (cg-RX-API-DMAC7.html)
JP (1) JP6854246B2 (cg-RX-API-DMAC7.html)
CN (1) CN107771285A (cg-RX-API-DMAC7.html)
ES (1) ES2806498T3 (cg-RX-API-DMAC7.html)
WO (1) WO2016198833A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6854246B2 (ja) * 2015-06-08 2021-04-07 アーケア ダイアグノスティクス リミテッド 尿サンプルの分析方法
KR101923199B1 (ko) * 2018-04-25 2018-11-28 주식회사 무진메디 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물
WO2019239514A1 (ja) * 2018-06-13 2019-12-19 日立化成株式会社 細胞溶解装置および細胞溶解方法
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
GB201912605D0 (en) * 2019-09-02 2019-10-16 Arquer Diagnostics Ltd Cancer assay
WO2021046368A1 (en) * 2019-09-05 2021-03-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and compounds modifying mitochondrial function
CN111323585A (zh) * 2020-02-27 2020-06-23 北京健平金星生物科技有限公司 一种核基质蛋白22酶联免疫检测试剂盒制备方法及试剂盒
CN112229995B (zh) * 2020-09-30 2024-07-05 北京安图生物工程有限公司 胃蛋白酶原pgi/ii复合校准品的稀释液及其应用
CN114878804A (zh) * 2022-05-23 2022-08-09 山东博科快速检测技术有限公司 一种用于胶体金法新冠病毒抗原检测卡的样本稀释液
CN115389291A (zh) * 2022-10-26 2022-11-25 北京肿瘤医院(北京大学肿瘤医院) 一种尿液微量蛋白的富集、纯化和保护方法
CN119178710B (zh) * 2024-11-19 2025-03-25 浙江博真生物科技有限公司 一种基于流式细胞术检测dna倍体的方法

Family Cites Families (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022576A (en) 1975-06-09 1977-05-10 I. C. L. Scientific Method and apparatus for preparation of liquids containing suspended material for examination
US4794076A (en) 1985-09-23 1988-12-27 Vxr, Inc. Simultaneous extraction of a ligand from a sample and capture by anti-ligands therefor in ligand/anti-ligand assays
GB8526741D0 (en) 1985-10-30 1985-12-04 Boots Celltech Diagnostics Binding assay device
US4868108A (en) 1985-12-12 1989-09-19 Hygeia Sciences, Incorporated Multiple-antibody detection of antigen
US5016644A (en) 1989-01-10 1991-05-21 La Mina Ltd. Urine testing module and method of collecting urine antigen
US5087556A (en) 1989-05-17 1992-02-11 Actimed Laboratories, Inc. Method for quantitative analysis of body fluid constituents
CA2040088A1 (en) 1991-04-09 1992-10-10 Raouf A. Guirguis Method for testing urine antigen
EP0509158A1 (en) 1991-04-10 1992-10-21 La Mina Ltd. Method of testing for urine antigen
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
EP0763738A1 (en) 1995-09-14 1997-03-19 Unipath Limited Assays for Chlamydia in diluted urine samples
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
CO5080817A1 (es) 1997-10-21 2001-09-25 Cancer Res Campaign Tech Ltd Determinacion de anormalidades en el crecimiento celular
US6008003A (en) 1997-10-28 1999-12-28 Promega Corporation Non-invasive diagnostic method for interstitial cystitis and bladder cancer
EP1388734B1 (en) 2002-08-01 2004-03-03 MTM Laboratories AG Method for solution based diagnosis
AUPP713498A0 (en) 1998-11-17 1998-12-10 Chandler, Howard Milne A method of detecting blood
AU2397200A (en) 1998-12-30 2000-07-31 Sedum Laboratories Tetramethylbenzidine formulation with increased performance for horseradish peroxidase enzyme assays
DE19915057A1 (de) 1999-04-01 2000-10-19 Forschungszentrum Borstel Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung
AU5698500A (en) 1999-07-06 2001-01-22 Cancer Research Ventures Limited Assay method to identify s-phase cells on cell sections or permeabilised cells and uses thereof
DE19936618A1 (de) 1999-08-04 2001-03-15 Monotec Gmbh Diagnostisches Kit und dessen Verwendung
US20050208558A1 (en) 1999-10-19 2005-09-22 Applera Corporation Detection kits, such as nucleic acid arrays, for detecting the expression or 10,000 or more Drosophila genes and uses thereof
AU2001245945A1 (en) 2000-03-23 2001-10-03 Pe Corporation (Ny) Detection kits, such as nucleic acid arrays, for detecting the expression of 10,000 or more drosophila genes and uses thereof
US20070037165A1 (en) 2000-09-08 2007-02-15 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US6812339B1 (en) 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
DE10054632B4 (de) 2000-11-03 2007-07-26 Michael Prof. Dr.med. Giesing Verfahren zur Isolierung von disseminierten Krebszellen aus einer zellhaltigen Körperflüssigkeit und Verwendung einer Filtervorrichtung in einem solchen Verfahren
US20040241876A1 (en) 2000-12-22 2004-12-02 France Fannes Flow through assay device, diagnostic kit comprising said assay device and use of said assay device in the detection of an analyte present in a sample
KR100420400B1 (ko) 2001-04-30 2004-03-04 (주)이인 액상의 다기능성 원적외선 방사체 및 그의 용도
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2003024993A2 (en) 2001-09-20 2003-03-27 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
US20070237770A1 (en) 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
EP2388265A1 (en) 2002-02-22 2011-11-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1507148B1 (en) 2003-08-25 2005-02-23 MTM Laboratories AG Method for detecting carcinomas in a solubilized cervical body sample
DE10238046A1 (de) 2002-08-20 2004-03-04 Giesing, Michael, Prof. Dr.med. Verfahren zum Untersuchen von Körperflüssigkeiten auf Krebszellen, dessen Verwendung, entsprechende Analysekits und Verwendung bestimmter Wirkstoffe zur Behandlung von Krebs
AU2003289716A1 (en) 2002-09-12 2004-04-30 Incyte Corporation Molecules for diagnostics and therapeutics
WO2004035783A2 (en) 2002-09-26 2004-04-29 Cellzome Ag Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway
WO2004030615A2 (en) 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
JP2006517785A (ja) 2002-10-29 2006-08-03 ジェネンテック・インコーポレーテッド 免疫関連疾患の治療のための新規組成物と方法
AU2003295401B2 (en) 2002-11-08 2010-04-29 Genentech, Inc. Compositions and methods for the treatment of natural killer cell related diseases
CA2515075C (en) 2003-02-05 2012-10-02 Iquum, Inc. Sample processing
DE10316701A1 (de) 2003-04-09 2004-11-04 Hinzmann, Bernd, Dr. Humane Nukleinsäuresequenzen aus Bronchialkarzinomen
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
EP1510820B1 (en) 2003-08-25 2010-03-17 MTM Laboratories AG Method for detecting medically relevant conditions in a solubilized LBC sample
TW200510721A (en) 2003-08-29 2005-03-16 Toshiba Kk Color reagent, concentration measuring kit, concentration measuring method and sensor chip for use therein
EP1670827A2 (en) 2003-09-05 2006-06-21 Eli Lilly And Company Anti-ghrelin antibodies
JP2005080524A (ja) 2003-09-05 2005-03-31 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法
US20050069900A1 (en) 2003-09-25 2005-03-31 Cytyc Corporation Analyte sample detection
US8344211B2 (en) 2008-08-13 2013-01-01 Ceres, Inc. Plant nucleotide sequences and corresponding polypeptides
WO2005085860A2 (en) 2004-02-27 2005-09-15 Institut Curie New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
US7604956B2 (en) 2004-03-01 2009-10-20 Biotraces, Inc. Supersensitive immunoassays
EP1756577B1 (en) 2004-03-24 2012-03-14 Tripath Imaging, Inc. Methods and compositions for the detection of cervical disease
EP1757306A4 (en) 2004-04-09 2010-05-19 Genecare Res Inst Co Ltd AGENT INDUCING APOPTOSIS SPECIFIC TO CARCINOMA CELLS TARGETING A GENE INVOLVED IN STABILIZING CHROMOSOMES
JP4685369B2 (ja) 2004-04-30 2011-05-18 独立行政法人科学技術振興機構 関節リウマチ診断用試薬
AU2011236061B2 (en) 2004-07-23 2015-02-19 Pacific Edge Limited Urine markers for detection of bladder cancer
CA3147162A1 (en) 2004-07-23 2006-02-02 Pacific Edge Limited Urine markers for detection of bladder cancer
EP1628135A1 (en) * 2004-08-20 2006-02-22 MTM Laboratories AG Method for detecting medically relevant conditions in a solubilized LBC sample
US20090163406A1 (en) 2004-09-30 2009-06-25 The Regents Of The University Of California Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells
US8951746B2 (en) * 2004-11-05 2015-02-10 Southwest Research Institute Method and devices for screening cervical cancer
WO2006071970A2 (en) 2004-12-23 2006-07-06 Georgetown University Methods for the detection of analytes in a sample
WO2006086573A2 (en) 2005-02-09 2006-08-17 The United States Of America As Represented By The Secretary Of The Navy Diagnostic assay for orientia tsutsugamushi by detection of responsive gene expression
FR2883488B1 (fr) 2005-03-24 2010-12-10 Inst Nat Sante Rech Med Procede et dispositif pour separer par filtration verticale des particules biologiques contenues dans un liquide
US7595380B2 (en) 2005-04-27 2009-09-29 Tripath Imaging, Inc. Monoclonal antibodies and methods for their use in the detection of cervical disease
US7842467B1 (en) 2005-05-12 2010-11-30 Celera Corporation Breast disease targets and uses thereof
CA2608315C (en) 2005-05-13 2014-08-05 Centre National De La Recherche Scientifique Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions
KR101068612B1 (ko) 2005-05-24 2011-09-30 휴마시스 주식회사 유사구조 단백질 비율 측정을 이용한 진단장치
EP1916301A4 (en) 2005-08-11 2009-04-01 Banyu Pharma Co Ltd METHOD OF EVALUATING A COMPOUND USING A MOLECULE ON THE RB WAY AS INDEX AND A MOLECULAR DIAGNOSTIC PROCESS
GB0518877D0 (en) 2005-09-15 2005-10-26 Medical Res Council Markers and methods
EP1775590A1 (en) 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
GB0521521D0 (en) 2005-10-21 2005-11-30 Medical Res Council Diagnostic methods and kits
KR20080080525A (ko) 2005-12-08 2008-09-04 노파르티스 아게 유전자 전사에 대한 ｆｇｆｒ３의 억제제의 효과
ATE437355T1 (de) 2006-02-03 2009-08-15 Mtm Lab Ag Verfahren zur durchführung eines denaturierungs- immunoassays
US20070184460A1 (en) 2006-02-09 2007-08-09 Wei-Mei Ching Diagnostic assay for Orientia tsutsugamushi by detection of responsive gene expression
BRPI0708976A2 (pt) 2006-03-24 2011-07-05 Basf Plant Science Gmbh célula de planta, planta, semente, molécula de ácido nucleico isolada, construção de ácido nucleico, vetor, célula hospedeira, proteìna relacionada com estresse isolada, métodos para produzir uma planta transgênica e para modificar a toleráncia a estresse de uma planta, e, usos de um ácido nucleico codificando srp e de toleráncia e/ou resistência aumentadas a estresse ambiental e/ou um ácido nucleico codificando srp
EP1852186A1 (en) * 2006-05-03 2007-11-07 Eppendorf Array Technologies Method and means for multiparametric assays being compartmentalized
WO2008021290A2 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
US20100094560A1 (en) 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100222228A1 (en) 2006-10-11 2010-09-02 Janssen Pharmaceutica N.V. Compositions and methods for treating and diagnosing irritable bowel syndrome
KR100886670B1 (ko) 2007-01-11 2009-03-04 김현기 유두갑상선암의 새로운 진단마커 및 진단방법
ES2304306B1 (es) 2007-03-20 2009-07-07 Indas Biotech, S.L.U. Metodo de diagnostico y/o pronostico de cancer vesical.
US20080254455A1 (en) * 2007-04-12 2008-10-16 Haiying Wang Detecting prostate cancer
GB0708002D0 (en) 2007-04-25 2007-06-06 Univ Sheffield Antibodies
CN101801431B (zh) 2007-06-22 2014-11-19 循环生物制品有限责任公司 流体浓缩器和自体浓缩体液及其使用方法
JP5196890B2 (ja) 2007-06-29 2013-05-15 オリンパス株式会社 有核細胞回収装置および有核細胞の回収方法
WO2009020596A2 (en) 2007-08-03 2009-02-12 Beth Israel Deaconess Medical Center Embryonic cerebrospinal fluis (e-csf), proteins from e-csf, and related methods and compositions
JP5515740B2 (ja) 2007-09-27 2014-06-11 国立大学法人 新潟大学 尿中タンパク質定量用の尿前処理剤、尿前処理方法、及び尿中タンパク質定量方法。
CA2934220C (en) 2007-10-02 2019-11-05 Theranos, Inc. Modular point-of-care devices and uses thereof
GB0720113D0 (en) 2007-10-15 2007-11-28 Cambridge Cancer Diagnostics L Diagnostic, prognostic and predictive testing for cancer
WO2009145815A2 (en) 2008-04-01 2009-12-03 The Brigham And Women's Hospital, Inc. Biomarkers of ovarian cancer
CN101358976A (zh) 2008-04-28 2009-02-04 北京华大吉比爱生物技术有限公司 检测六项肿瘤标志物的微阵列-酶联免疫检测试剂盒
JP2011521215A (ja) 2008-05-14 2011-07-21 エーテーハー チューリヒ 前立腺癌の診断及び治療のためのバイオマーカー及び薬剤標的発見法、並びにそれを用いて決定されるバイオマーカーアッセイ
GB0811567D0 (en) * 2008-06-24 2008-07-30 Cytosystems Ltd Assay
US8071815B2 (en) 2008-07-17 2011-12-06 Arup Kumar Indra CTIP2 expression in squamous cell carcinoma
ES2663698T3 (es) 2008-09-04 2018-04-16 Ventana Medical Systems, Inc. Procedimiento para la predicción del riesgo de progresión de tumores
JP2010088376A (ja) 2008-10-09 2010-04-22 Olympus Corp 細胞回収装置および脂肪由来細胞含有液
WO2010042228A2 (en) 2008-10-10 2010-04-15 Cornell University Methods for predicting disease outcome in patients with colon cancer
WO2010048123A2 (en) 2008-10-20 2010-04-29 Eckhardt S Gail Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
CN101738469A (zh) 2008-11-19 2010-06-16 中国海洋大学 一种基于可视化蛋白芯片的食物过敏原检测方法
KR101343035B1 (ko) 2008-12-22 2013-12-18 삼성전자 주식회사 제1수용체, 차단물질 및 제2수용체가 고정화된 고체 기판을포함하는 표적물질을 분석하기 위한 물품 및 그 용도
US8377643B2 (en) 2009-03-16 2013-02-19 Abaxis, Inc. Split flow device for analyses of specific-binding partners
US20100240546A1 (en) 2009-03-20 2010-09-23 Samuel Chun Lap Lo Use of biomarkers for the diagnosis and prognosis of lung cancer
WO2010125566A2 (en) * 2009-04-27 2010-11-04 Technion Research And Development Foundation Ltd. Markers for cancer detection
CN101993926A (zh) 2009-08-10 2011-03-30 芮屈生物技术（上海）有限公司 一种mcm2基因的原位杂交检测试剂盒及其检测方法和应用
GB0921873D0 (en) 2009-12-15 2010-01-27 Cytosystems Ltd Assay
US9267948B2 (en) 2009-12-30 2016-02-23 Brigham Young University Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
CA2788113A1 (en) 2010-02-03 2011-08-11 President And Fellows Of Harvard College Devices and methods for multiplexed assays
WO2011109705A2 (en) 2010-03-04 2011-09-09 Purdue Research Foundation Integrated assay that combines flow-cytometry and multiplexed hpv genotype identification
WO2011126482A1 (en) 2010-04-07 2011-10-13 Egenix, Inc. Immunoassay for the diagnosis of prostate cancer
SE535084C2 (sv) 2010-04-16 2012-04-10 Prostasom Handelsbolag Förfarande för cancerdiagnos
US20110262921A1 (en) 2010-04-23 2011-10-27 Sabichi Anita L Test for the Detection of Bladder Cancer
US8900813B2 (en) 2010-08-17 2014-12-02 Medical Diagnostic Laboratories, Llc CIP2A as a biomarker in detection of cervical cancer
EP2625528B1 (en) 2010-10-08 2016-11-23 Cellanyx Diagnostics, LLC Systems and methods and devices for measuring oncogenic and metastatic potential
US8658376B2 (en) * 2010-10-20 2014-02-25 Medical Diagnostic Laboratories, Llc DEK as a urine based biomarker for bladder cancer
WO2012065117A2 (en) 2010-11-12 2012-05-18 William Marsh Rice University Oral cancer point of care diagnostics
WO2012090479A1 (en) 2010-12-28 2012-07-05 Oncotherapy Science, Inc. Mcm7 as a target gene for cancer therapy and diagnosis
GB201100223D0 (en) 2011-01-07 2011-02-23 Cytosystems Ltd Diagnostic method
US20130136786A1 (en) 2011-02-10 2013-05-30 Sanford-Burnham Medical Research Institute Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent
RU2470301C2 (ru) 2011-03-16 2012-12-20 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН Способ диагностики рака мочевого пузыря с помощью онкомаркера kifc1 (варианты) и набор для его осуществления
RU2463354C1 (ru) 2011-03-16 2012-10-10 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН Способ диагностики рака мочевого пузыря с помощью онкомаркера tfdp1 (варианты) и набор для его осуществления
CN102707063A (zh) 2011-03-28 2012-10-03 侯亚义 微小染色体维持蛋白在系统性红斑狼疮疾病诊断和防治中的作用
RU2456607C1 (ru) 2011-04-27 2012-07-20 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГУ "РНЦРХТ" Минздравсоцразвития России) Способ диагностики переходноклеточного рака мочевого пузыря
EP2705366B1 (en) 2011-05-04 2017-07-12 Pop Test LLC Diagnostic device
CN102375061B (zh) 2011-09-20 2014-07-30 国家人口计生委科学技术研究所 一种检测前列腺癌的elisa试剂盒
US20130115599A1 (en) 2011-11-08 2013-05-09 Medical Diagnostic Laboratories, Llc Increased cip2a expression and bladder cancer in humans
CA2854665A1 (en) 2011-11-10 2013-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene expression signatures of neoplasm responsiveness to therapy
GB201200178D0 (en) 2012-01-06 2012-02-22 Cytosystems Ltd Diagnostic method and system
CN102998455B (zh) 2012-02-14 2016-01-13 昂科生物医学技术(苏州)有限公司 一种检测或诊断前列腺癌的试剂盒
ES2796253T3 (es) 2012-02-15 2020-11-26 Biocon Ltd Un proceso para la detección y la cuantificación opcional de un analito
EP2834260A4 (en) 2012-04-02 2016-08-10 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PREPARATION OF MEMBRANE PROTEINS
JP2012196211A (ja) 2012-04-10 2012-10-18 Japan Science & Technology Agency 前立腺癌マーカポリペプチド、該ポリペプチドに対する抗体、及び該ポリペプチドを利用した前立腺癌の診断方法
WO2013181418A2 (en) 2012-05-30 2013-12-05 Clarient Diagnostic Services, Inc. Multiplexed diagnosis method for classical hodgkin lymphoma
US20150147761A1 (en) 2012-06-20 2015-05-28 Helmut E. Meyer Specific biomarkers for hepatocellular carcinoma (hcc)
EP2875157A4 (en) 2012-07-20 2016-10-26 Diagnocure Inc METHOD, KITS AND COMPOSITIONS FOR THE CLINICAL EVALUATION OF PROSTATE CANCER
US10613087B2 (en) 2012-08-10 2020-04-07 Analiza, Inc. Methods and devices for analyzing species to determine diseases
WO2014032899A1 (en) * 2012-08-31 2014-03-06 Novo Nordisk A/S Diagnosis and treatment of lupus nephritis
US20150226743A1 (en) 2012-10-28 2015-08-13 Clarient Diagnostics Services, Inc. Multiplexed method for diagnosing classical hodgkin lymphoma
WO2014071029A1 (en) 2012-10-31 2014-05-08 The General Hospital Corporation Methods and assays for treatment of bladder cancer
RU2522231C1 (ru) 2012-11-14 2014-07-10 Евгений Иосифович Гоуфман Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
MY176888A (en) 2012-11-26 2020-08-25 Univ Sains Malaysia Method for detection of target analyte(s)
US8945827B2 (en) * 2013-03-13 2015-02-03 Awareness Technology, Inc. Serological methods and diagnostic tests for syphilis antibodies
GB201316347D0 (en) * 2013-09-13 2013-10-30 Cancer Rec Tech Ltd Biological fluid filtration assembly
CN103558384A (zh) 2013-11-08 2014-02-05 点亮生物科技无锡有限公司 一种同时检测四种肿瘤标志物的化学发光试剂盒及其制备方法
CN103725599B (zh) 2014-01-14 2015-05-27 刘韬 一种流体膜过滤细胞分离装置
KR101627408B1 (ko) 2014-03-06 2016-06-03 김홍 고농축 혈장 추출장치 및 방법
JP6854246B2 (ja) * 2015-06-08 2021-04-07 アーケア ダイアグノスティクス リミテッド 尿サンプルの分析方法
EP4060344A1 (en) * 2015-06-08 2022-09-21 Arquer Diagnostics Limited Methods and kits

Also Published As

Publication number Publication date
US20180203012A1 (en) 2018-07-19
CN107771285A (zh) 2018-03-06
EP3304082A2 (en) 2018-04-11
EP3304082B1 (en) 2020-05-13
JP2018523110A (ja) 2018-08-16
US20230184773A1 (en) 2023-06-15
WO2016198833A2 (en) 2016-12-15
WO2016198833A3 (en) 2017-03-16
US11519916B2 (en) 2022-12-06
ES2806498T3 (es) 2021-02-17

Similar Documents

Publication Publication Date Title
JP6854246B2 (ja) 尿サンプルの分析方法
EP2115472B1 (en) Cancer biomarkers
US20220260588A1 (en) Methods and kits
KR102384848B1 (ko) 방광암용 바이오마커로서의 케라틴 17
US20210231667A1 (en) Method for detecting or monitoring prostate cancer
CN101680898A (zh) Timp-1作为结肠直肠癌标志的用途
US20220381785A1 (en) Cancer Detection Method
CN101539574A (zh) Survivin抗体的应用及以其制备的食管癌免疫层析检测试纸条
CN106461666B (zh) 检测癌症的方法
Poh et al. Prostate-specific antigen in breast disease
WO2011031560A2 (en) Materials and methods for the differential diagnosis of pancreatic lesions
JP2021117117A (ja) 前立腺癌のバイオマーカー及び該バイオマーカーを用いた前立腺癌を検出するための方法並びに診断キット
JP2012519290A (ja) 肺の扁平上皮癌のためのマーカーとしてのセルピンｂ１３
US20220050110A1 (en) Use of mcm5 as a marker in semen for prostate cancer
Sachdev et al. Characterization of a Cancer Biomarker Sas1b for the Early Detection of Cervical Cancer
CN110546510A (zh) 预后方法和在所述方法中有用的试剂盒
HK1142130A (en) Use of timp-1 as a marker for colorectal cancer

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20180822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190531

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190531

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200519

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210315

R150 Certificate of patent or registration of utility model

Ref document number: 6854246

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees